CLINICAL_TRIALS
trial_result
· 2023-09-28
Clinical Trial Update: Preventing Anaphylaxis With Acalabrutinib [Phase 2]
Summary
Phase 2 clinical trial update on acalabrutinib for preventing anaphylaxis in individuals with food allergy, completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Johns Hopkins University | Conditions: Food Allergy, Food Allergy Peanut | Phase 2 | Status: COMPLETED | Results posted: 2023-09-28